 NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents.
Scroll down for information and opportunities that may be of interest. |
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts January 14, 2022 |
General Notices Notices of Changes to Funding Opportunities Notices of Special Interest Funding Opportunities - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
(PAR-21-357)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
- Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
(PAR-21-359)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
- Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
(PAR-21-360)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
(PAR-22-041)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
(PAR-22-042)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
(PAR-22-043)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
(PAR-22-044)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
(PAR-22-045)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
(PAR-22-046)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
(PAR-22-060)
National Institute of Dental and Craniofacial Research
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): January 07, 2025
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
(PAR-22-090)
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): January 07, 2025
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
(PAR-22-091)
National Cancer Institute
Application Receipt Date(s): January 07, 2025
- Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)
(PAR-22-092)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Nursing Research
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
- Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed
(PAR-22-108)
Food and Drug Administration
Application Receipt Date(s): May 2, 2022, by 11:59 PM Eastern Time. May 1, 2023, by 11:59 PM Eastern Time. May 1, 2024, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
(RFA-AR-22-009)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): April 11, 2022
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
(RFA-DA-22-037)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
(RFA-DA-22-038)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
- In Vitro Based Approaches to Evaluate the Bioequivalence of Prospective Generic Rectal and Vaginal Products (U01) Clinical Trial Not Allowed
(RFA-FD-22-014)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022
- In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required
(RFA-FD-22-015)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- Investigating the In Vivo Behavior and In Vitro Characteristics of a Purportedly Gastro-Retentive Extended Release Formulation to Elucidate Considerations Relevant to Generic Products (U01) Clinical Trials Required
(RFA-FD-22-018)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed
(RFA-FD-22-022)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)
(RFA-NS-22-045)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): March 24, 2022
- HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
(RFA-NS-22-046)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 24, 2022 |
| NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site. |
No comments:
Post a Comment